![Laurent Arthaud](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laurent Arthaud
Direktor/Vorstandsmitglied bei
CELLECTIS S.A.
Profil
Laurent Arthaud currently works at Argobio SAS, as Chairman-Supervisory Board, Cellectis SA, as Independent Director, Kurma Partners SA, as Director, Aledia SAS, as Director, ENYO Pharma SA, as Director from 2020, SparingVision SAS, as Director from 2020, Ribogenics, Inc., as Director from 2018, InnoBioChips SAS, as Director from 2009, and BPIFrance Investissement SAS, as Deputy General Manager from 2012.
Mr. Arthaud also formerly worked at CDC Croissance SA, as Deputy Chief Executive Officer, Pharmavent Partners, as President & Chief Executive Officer from 2004 to 2006, IntegraGen SA, as Director, SCYNEXIS, Inc., as Independent Director from 2014 to 2015, Demeter Ventures SA, as Director from 2006 to 2016, Sangamo Therapeutics France SAS, as Director from 2012 to 2018, Adocia SA, as Director from 2009 to 2022, Calyxt, Inc., as Director from 2017 to 2019, Emertee Gestion, as Director from 2006 to 2016, Calyxt, Inc., as Director from 2020 to 2023, Rhone-Poulenc SA, as General Secretary-Scientific Direction, and Aventis Capital, as Vice President from 1999 to 2004.
Mr. Arthaud received his undergraduate degree in 1984 from Ecole Polytechnique and undergraduate degree in 1986 from Ecole Nationale de la Statistique & de l'Administration.
Aktive Positionen von Laurent Arthaud
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLECTIS S.A. | Direktor/Vorstandsmitglied | 28.10.2011 |
Aledia SAS
 Aledia SAS Electrical ProductsProducer Manufacturing Develops and manufactures light-emitting diodes | Direktor/Vorstandsmitglied | - |
Argobio SAS
 Argobio SAS Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company | Vorsitzender | - |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Direktor/Vorstandsmitglied | 01.07.2020 |
Ribogenics, Inc.
 Ribogenics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | 01.12.2018 |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Direktor/Vorstandsmitglied | - |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology Develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa | Direktor/Vorstandsmitglied | - |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national. | Private Equity Investor | 07.04.2010 |
InnoBioChips SAS
 InnoBioChips SAS BiotechnologyHealth Technology Develops biochips peptides and proteins | Direktor/Vorstandsmitglied | 01.01.2009 |
Ehemalige bekannte Positionen von Laurent Arthaud
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Laurent Arthaud
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
22
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 22 |
|---|---|
IntegraGen SA
 IntegraGen SA Medical/Nursing ServicesHealth Services Develops cutting edge genome analysis products | Health Services |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Rhone-Poulenc SA
 Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Process Industries |
Demeter Ventures SA
 Demeter Ventures SA Investment ManagersFinance Demeter Ventures focuses on companies located across Europe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. Demeter Ventures reorganized its operating segments on May 11, 2021, by merger of Emertec Gestion with Demeter Ventures and now operating as Demeter Investment Managers SA. | Finance |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Ecole Polytechnique
 Ecole Polytechnique Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ecole Nationale de la Statistique & de l'Administration
 Ecole Nationale de la Statistique & de l'Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national. | Finance |
Aventis Capital
 Aventis Capital Investment ManagersFinance Alternative investment manager | Finance |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
CDC Croissance SA
 CDC Croissance SA Investment ManagersFinance CDC Croissance develops an investment strategy for their clients based on each client's financial goals, time horizon and risk tolerance. | Finance |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Finance |
Aledia SAS
Aledia SAS Electrical ProductsProducer Manufacturing Develops and manufactures light-emitting diodes | Producer Manufacturing |
Pharmavent Partners | |
Calyxt, Inc.
 Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
InnoBioChips SAS
InnoBioChips SAS BiotechnologyHealth Technology Develops biochips peptides and proteins | Health Technology |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology Develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa | Health Technology |
Emertee Gestion | |
Ribogenics, Inc.
Ribogenics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Argobio SAS
Argobio SAS Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company | Commercial Services |
